This question may seem counter intuitive, as we are exposed almost daily to the dire performance of clinical trials and their spiraling costs resulting from incurred delays. Metrics are indeed critical to efforts to rein in clinical trials that are either poorly initiated or have incurred unforeseen events which place the original timelines and/or budgets at risk of overages. They also drive competitive performance among those organizations performing trials. But how? The webinar will focus on these issues and the competitive edge metrics provide those organizations engaged in conducting clinical trials.
In this webinar we will explore:
This webinar is applicable to: